Why is $CYRX moving today? · SEC 8-K archive

$CYRX SEC Filing Alert & Real-Time AI Stock Impact Analysis

T0 SEO archive for $CYRX: filings appear instantly. AI score, direction and bullet analysis unlock publicly after 4 hours (VIP sees them live).

← All archive signals

FAQ: $CYRX filing catalyst

Why did $CYRX trigger an AI stock catalyst alert?

$CYRX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: +3.0/10). Headline: Cryoport Reports Q3 Revenue of $50.2M (+14% YoY), Raises FY Revenue Guidance. Key points: - Q3 revenue rose 14% YoY to $50.2M, driven by a 20% gain in commercial cell & gene therapy revenue. - FY revenue guidance raised to $197M-$199M, supporting a record 788 clinical trials. - Total gross margin contracted to 47.5% from 48.2%; net loss was $(0.25) per share.

How did $CYRX stock react after the SEC filing?

After the SEC 8-K for $CYRX, observed market reaction: T0 price $16.05. Past moves do not guarantee future results.

Where can I get real-time $CYRX SEC filing alerts?

Stock Catalyst AI pushes real-time SEC 8-K alerts for $CYRX via Telegram and the VIP Web Terminal from €10/month.

$CYRX

$CYRX – Cryoport Reports Q3 Revenue of $50.2M (+14% YoY), Raises FY Revenue Guidance

Cryoport, Inc.

2026-11-05 00:00:00 UTC · SEC 8-K · All $CYRX

Unlocked archive · Analyzed in <2s at T0

Bullish AI Sentiment (+3.0 / 10)

Q3 revenue rose 14% YoY to $50.2M, driven by a 20% gain in commercial cell & gene therapy revenue.
FY revenue guidance raised to $197M-$199M, supporting a record 788 clinical trials.
Total gross margin contracted to 47.5% from 48.2%; net loss was $(0.25) per share.

Unlock Live VIP Terminal & Telegram – €10/mo Original filing →